BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2833287)

  • 1. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast.
    Norris HJ; Bahr GF; Mikel UV
    Anal Quant Cytol Histol; 1988 Feb; 10(1):1-9. PubMed ID: 2833287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
    Crissman JD; Visscher DW; Kubus J
    Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein expression and nuclear DNA content in breast intraductal proliferations.
    Schmitt FC; Leal C; Lopes C
    J Pathol; 1995 Jul; 176(3):233-41. PubMed ID: 7674086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
    Purcell CA; Norris HJ
    Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization by image cytometry of duct epithelial proliferative disease of the breast.
    King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL
    Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphometric differentiation of intraductal proliferative breast lesions.
    Nagashima T; Suzuki M; Yagata H; Hashimoto H; Shishikura T; Imanaka N; Nakajima N
    Breast Cancer; 2000 Jan; 7(1):43-7. PubMed ID: 11029770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis.
    Schmitt FC; Figueiredo P; Lacerda M
    Arch Pathol Lab Med; 1995 Sep; 119(9):815-20. PubMed ID: 7668939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
    Ricevuti G; Barni S
    Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of cytometric analysis for distinction of intraductal carcinoma of the breast.
    Fisher ER; Siderits R
    Breast Cancer Res Treat; 1992; 21(3):165-72. PubMed ID: 1325216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochemical classification of nonpalpable breast carcinoma.
    Fallenius A; Svane G; Auer G; Caspersson TO
    Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression in intraductal epithelial hyperplasia, atypical intraductal hyperplasia, and intraductal carcinoma of the breast.
    Fischler DF; Sebek BA; Tubbs RR; Biscotti CV
    Histopathology; 1996 Jan; 28(1):93-4. PubMed ID: 8838130
    [No Abstract]   [Full Text] [Related]  

  • 14. [DNA determinations in breast cancers: cytophotometric proliferation behavior and cyto/histologic malignancy grade].
    Mikuz G
    Verh Dtsch Ges Pathol; 1985; 69():516-9. PubMed ID: 3006392
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.
    Tavassoli FA; Norris HJ
    Cancer; 1990 Feb; 65(3):518-29. PubMed ID: 2297643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluorometric grading of mammary tumors. A pilot study.
    Patek E; Johannisson E; Krauer F; Riotton G
    Anal Quant Cytol; 1980 Dec; 2(4):264-71. PubMed ID: 6258463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
    von Rosen A; Fallenius A; Sundelin B; Auer G
    Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometric studies for objective diagnosis of intraductal carcinoma of the breast.
    Tajima Y; Ishige H; Kondo Y
    Acta Pathol Jpn; 1991 Aug; 41(8):604-9. PubMed ID: 1661058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic pitfalls in mammary pathology. Case 2. Atypical duct hyperplasia within columnar cell changes with atypia].
    Vincent-Salomon A
    Ann Pathol; 2009 Jun; 29(3):194-8. PubMed ID: 19619825
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy.
    Prowler VL; Joh JE; Acs G; Kiluk JV; Laronga C; Khakpour N; Lee MC
    Breast; 2014 Aug; 23(4):352-6. PubMed ID: 24518220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.